SCHEMBL3424129

SCHEMBL3424129

CCCCCCCCCCCCCCCCCC([O])(O)O

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GGPS1 O95749 7/20 0.56
FDPS P14324 10/20 0.54
SMPD1 P17405 2/20 0.48
CES2 O00748 1/20 0.46
LPAR1 Q92633 1/20 0.46
LPAR3 Q9UBY5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6142749 1.00 GGPS1 (0.56) GGPS1FDPSSMPD1CES2LPAR1
SCHEMBL11444882 0.97
SCHEMBL14892700 0.88
SCHEMBL31633496 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2
SCHEMBL2331498 0.78 FDPS (0.48) GGPS1FDPSSMPD1
SCHEMBL16970226 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2
SCHEMBL16969753 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2
SCHEMBL16969757 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2
SCHEMBL16970082 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2
SCHEMBL16969952 0.78 FDPS (0.48) GGPS1FDPSSMPD1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130053331-A1 SUGAR DERIVATIVES, METHODS FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS L'Air Liquide, Societe Anonyme pour l'Etude et ,'Exploitation des Procedes Georges Claude (FR) 2013-02-28 US disclosed
US-20100168252-A1 SUGAR DERIVATIVES, METHOD FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS SOCIETE D'EXPLOITATION DES PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168252-A1 SUGAR DERIVATIVES, METHOD FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS SGMS1, MAN1B1, MSR1 GGPS1 3418/4885FDPS 3874/4885SMPD1 277/4885
US-20130053331-A1 SUGAR DERIVATIVES, METHODS FOR PREPARATION THEREOF, THEIR USE AS SURFACE-ACTIVE AGENTS SOD1, FUT4, MSR1 GGPS1 4186/4885FDPS 3298/4885SMPD1 1201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.